IMPORTANT SAFETY INFORMATION: Simparica is for use only in dogs, 8 weeks of age and older. Simparica has not been evaluated in dogs that are pregnant, breeding or lactating.
Available from your nearest Veterinary Clinic or Vetshop.
IMPORTANT SAFETY INFORMATION: Simparica is for use only in dogs, 8 weeks of age and older. Simparica has not been evaluated in dogs that are pregnant, breeding or lactating.
References: References: 1. Six RH, Geurden T, Carter L, et al. Evaluation of the speed of kill of sarolaner (Simparica™) against induced infestations of three species of ticks (Amblyomma maculatum, Ixodes scapularis, Ixodes ricinus) on dogs. Vet Parasitol. 2016;222:37-42. 2. Six RH, Everett WR, Young DR, et al. Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States. Vet Parasitol. 2016;222:28-32. 3. Tickborne diseases. National Institute of Allergy and Infectious Diseases website. https://www.niaid.nih.gov/diseases-conditions/tickborne-diseases. Updated March 4, 2016. Accessed April 20, 2017. 4. CAPC guidelines: Ticks for dogs. Companion Animal Parasite Council website. https://www.capcvet.org/guidelines/ticks/. Updated April 4, 2017. Accessed April 20, 2017. 5. Mapping Lyme disease enzootic risk and linking to disease outcomes in the United States. Yale School of Public Health website. https://publichealth.yale.edu/emd/research/zoonosis/projects/tick.aspx. Updated June 26, 2013. Accessed April 21, 2017. 6. Centers for Disease Control and Prevention. Tickborne diseases of the United States. A reference manual for health care providers. Third edition, 2015. https://www.cdc.gov/lyme/resources/tickbornediseases.pdf. Accessed April 21, 2017. 7. Life cycle of hard ticks that spread disease. Centers for Disease Control and Prevention website. https://www.cdc.gov/ticks/life_cycle_and_hosts.html. Updated June 1, 2015. Accessed April 21, 2017. 8. Little SE. Changing paradigms in understanding transmission of canine tick-borne diseases: the role of interrupted feeding and intrastadial transmission. Proceedings of the 2nd Canine Vector-Borne Disease (CVBD) Symposium; April 25-28, 2007; Sicily, Italy. http://www.cvbd.org/fileadmin/media/cvbd/Proceedings_CVBD_2007_FINAL23042007.pdf. Accessed April 21, 2017. 9. CAPC guidelines: Fleas for dogs. Companion Animal Parasite Council website. https://www.capcvet.org/guidelines/fleas/. Updated November 1, 2016. Accessed April 21, 2017. 10. Typhus. MedlinePlus website. https://www.nlm.nih.gov/medlineplus/ency/article/001363.htm. Updated April 4, 2014. Accessed April 21, 2017. 11. Plague. World Health Organization website. http://www.who.int/topics/plague/en/. Accessed April 21, 2017. 12. Bartonella. Lymedisease.org website. https://www.lymedisease.org/lyme-basics/co-infections/bartonella/. Accessed April 21, 2017.
For animal use only.
SIMPARICA 5 mg (chewable tablets for dogs). Reg. No.: G4317 (Act 36/1947). Each chewable tablet contains 5 mg sarolaner. SIMPARICA 10 mg (chewable tablets for dogs). Reg. No.: G4322 (Act 36/1947). Each chewable tablet contains 10 mg sarolaner. SIMPARICA 20 mg (chewable tablets for dogs). Reg. No.: G4318 (Act 36/1947). Each chewable tablet contains 20 mg sarolaner. SIMPARICA 40 mg (chewable tablets for dogs). Reg. No.: G4319 (Act 36/1947). Each chewable tablet contains 40 mg sarolaner. SIMPARICA 80 mg (chewable tablets for dogs). Reg. No.: G4320 (Act 36/1947). Each chewable tablet contains 80 mg sarolaner. SIMPARICA 120 mg (chewable tablets for dogs). Reg. No.: G4321 (Act 36/1947). Each chewable tablet contains 120 mg sarolaner. For “WARNINGS” refer to the approved package insert. For full prescribing information refer to the package insert approved by the medicines regulatory authority.
Full product information available from Zoetis South Africa (Pty) Ltd., Co. Reg. No.: 2012/001825/07. 6th Floor, North Wing, 90 Rivonia Road, Sandton, 2196. PostNet Suite 53, Private Bag 9976, Sandton, 2146, South Africa. Tel.: +27 11 245 3300 or 0860 ZOETIS (0860 963847). www.zoetis.co.za